✦ LIBER ✦

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

✍ Scribed by Arinobu Tojo; Kensuke Usuki; Akio Urabe; Yasuhiro Maeda; Yukio Kobayashi; Itsuro Jinnai; Kazuma Ohyashiki; Miki Nishimura; Tatsuya Kawaguchi; Hideo Tanaka; Koichi Miyamura; Yasushi Miyazaki; Timothy Hughes; Susan Branford; Shinichiro Okamoto; Jun Ishikawa; Masaya Okada; Noriko Usui; Hiromi Tanii; Taro Amagasaki; Hiroko Natori; Tomoki Naoe

Book ID: 107618778
Publisher: Carden Jennings Publishing
Year: 2009
Tongue: English
Weight: 184 KB
Volume: 89
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0327-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of nilotinib in Japa

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

✍ Kensuke Usuki; Arinobu Tojo; Yasuhiro Maeda; Yukio Kobayashi; Akira Matsuda; Kaz 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 285 KB

Nilotinib in imatinib-resistant or imati

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

✍ Giles, F J; le Coutre, P D; Pinilla-Ibarz, J; Larson, R A; Gattermann, N; Ottman 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 383 KB

Phase I and II pharmacokinetic and pharm

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma

✍ Yoshiaki Ogawa; Kensei Tobinai; Michinori Ogura; Kiyoshi Ando; Takahide Tsuchiya 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Combination of topotecan with cytarabine

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Char 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 67 KB

Phase II study of a TLR-9 agonist (1018

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

✍ Jonathan W. Friedberg; Jennifer L. Kelly; Donna Neuberg; Derick R. Peterson; Jef 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

I-99. A phase II efficacy study of brost

I-99. A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients with platinum refractory or resistant non-small cell lung cancer (NSCLC)

✍ Sandler, A.; Natale, R.; Blajman, C.; Kalemkerian, G.; Drinkard, L.; Fein, L.; C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 74 KB